CIK 0001817229
- Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811591163
- Phone
- +1 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 330,706 shares at $15.30 ($5,059,802)
- 4 Open-market sale Director sold 330,706 shares at $15.30 ($5,059,802)
- 4 Option exercise Chief Scientific Officer acquired 17,446 shares (option exercise)
- 4 Other acquisition Director acquired 998,382 shares (other)
- 4 Conversion 10% owner acquired 282,804 shares (conversion)
- 4 Open-market buy Director bought 2,979,566 shares at $18.00 ($53,632,188)
- 4 Open-market buy 10% owner bought 555,555 shares at $18.00 ($9,999,990)
- 4 Conversion Chief Financial Officer acquired 3,534 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 3,534 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 555,555 shares at $18.00 ($9,999,990)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 11 · 212 filings